About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [116 citations: 1–100 of 107 articles]

Articles published in Schizophrenia Research and Treatment have been cited 116 times. The following is a list of the 107 articles that have cited the articles published in Schizophrenia Research and Treatment.

  • Jin Dang, Jiangtao Zhang, Zhongwei Guo, Weihong Lu, Jun Cai, Zhongying Shi, and Chen Zhang, “A Pilot Study of iPad-assisted Cognitive Training for Schizophrenia,” Archives of Psychiatric Nursing, 2014. View at Publisher · View at Google Scholar
  • Tania M. Lincoln, Jonas Stahnke, and Steffen Moritz, “The Short-Term Impact of a Paranoid Explanation on Self-esteem: An Experimental Study,” Cognitive Therapy and Research, 2014. View at Publisher · View at Google Scholar
  • Marie-Hélène Lafeuille, Jason Dean, Valerie Carter, Mei Sheng Duh, John Fastenau, Riad Dirani, and Patrick Lefebvre, “Systematic Review of Long-Acting Injectables versus Oral Atypical Antipsychotics on Hospitalization in Schizophrenia,” Current Medical Research and Opinion, pp. 1–43, 2014. View at Publisher · View at Google Scholar
  • Raquel Iniesta, Susana Ochoa, Jesus Cobo, Eva Miquel, Mercedes Roca, Antoni Serrano-Blanco, Fernando Teba, and Judith Usall, “Effects of raloxifene on cognition in postmenopausal women with schizophren ia: A double-blind, randomized, placebo-controlled trial,” European Neuropsychopharmacology, vol. 24, no. 2, pp. 223–231, 2014. View at Publisher · View at Google Scholar
  • Marc De Hert, Johan Detraux, and Joseph Peuskens, “Second-generation and newly approved antipsychotics, serum prolactin levels and sexual dysfunctions: a critical literature review,” Expert Opinion on Drug Safety, pp. 1–20, 2014. View at Publisher · View at Google Scholar
  • Carol Curtin, Mirjana Jojic, and Linda G. Bandini, “Obesity in Children with Autism Spectrum Disorder,” Harvard Review of Psychiatry, vol. 22, no. 2, pp. 93–103, 2014. View at Publisher · View at Google Scholar
  • Cynthia A. Bossie, Jennifer K. Sliwa, Yi-Wen Ma, and Larry Alphs, “Paliperidone palmitate versus oral risperidone and risperidone long-acting injection in patients with recently diagnosed schizophrenia: a tolerability and efficacy comparison,” International Clinical Psychopharmacology, vol. 29, no. 1, pp. 45–55, 2014. View at Publisher · View at Google Scholar
  • Hans-Juergen Moller, Torgny H. Svensson, Mark A. Geyer, Dan Rujescu, Elizabeth Scarr, and Mark J. Millan, “Problems and solutions to filling the drying drug pipeline for psychiatric disorders: a report from the inaugural 2012 CINP Think Tank,” International Journal of Neuropsychopharmacology, vol. 17, no. 1, pp. 137–148, 2014. View at Publisher · View at Google Scholar
  • N.A. Uranova, O.V. Vikhreva, V.I. Rachmanova, and D.D. Orlovskaya, “Microglial activation in white matter in schizophrenia: Findings from a postmortem electron microscopic morphometric study,” Neurology, Psychiatry and Brain Research, vol. 20, no. 1, pp. 25, 2014. View at Publisher · View at Google Scholar
  • Nmaculada Ibanez-Casas, Sandra Saldivia, Dinarte Ballester, Pamela Grandon, Berta Moreno-Kuestner, Miguel Xavier, and Manuel Gomez-Beneyto, “Unmet needs in the management of schizophrenia,” Neuropsychiatric Disease and Treatment, vol. 10, pp. 97–110, 2014. View at Publisher · View at Google Scholar
  • Ali Mohammad Pourrahimi, Shahrzad Mazhari, Mohammad Shabani, and Vahid Sheibani, “An evidence for lack of pseudoneglect in patients with schizophrenia: An ERP study,” Neuroscience Letters, vol. 561, pp. 96–100, 2014. View at Publisher · View at Google Scholar
  • Qingsheng Zhang, Jiamei Lian, Meng He, Chao Deng, Hongqin Wang, and Xu-Feng Huang, “Olanzapine reduced brown adipose tissue thermogenesis and locomotor activity in female rats,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2014. View at Publisher · View at Google Scholar
  • Kim Donoghue, Gillian A. Doody, Robin M. Murray, Peter B. Jones, Craig Morgan, Paola Dazzan, Jozella Hart, Rodolfo Mazzoncini, and James H. MacCabe, “Cannabis use, gender and age of onset of schizophrenia: Data from the ÆSOP study,” Psychiatry Research, 2014. View at Publisher · View at Google Scholar
  • Steffen Moritz, Anja S. Göritz, Niels Van Quaquebeke, Christina Andreou, David Jungclaussen, and Maarten J. Peters, “Knowledge corruption for visual perception in individuals high on paranoia,” Psychiatry Research, 2014. View at Publisher · View at Google Scholar
  • Ponnada A. Narayana, Juan J. Herrera, Kurt H Bockhorst, Emilio Esparza-Coss, Ying Xia, Joel L. Steinberg, and F. Gerard Moeller, “Chronic cocaine administration causes extensive white matter damage in brain: Diffusion tensor imaging and immunohistochemistry studies,” Psychiatry Research: Neuroimaging, 2014. View at Publisher · View at Google Scholar
  • Carol P. Weingarten, and Timothy J. Strauman, “Neuroimaging for psychotherapy research: Current trends,” Psychotherapy Research, pp. 1–29, 2014. View at Publisher · View at Google Scholar
  • Rene S. Kahn, Marcel A. de Reus, Wiepke Cahn, and Martijn P. van den Heuvel, “Impaired Rich Club Connectivity in Unaffected Siblings of Schizophrenia Pat ients,” Schizophrenia Bulletin, vol. 40, no. 2, pp. 438–448, 2014. View at Publisher · View at Google Scholar
  • Fabian Lamster, Winfried Rief, Tania M. Lincoln, Martin Wiesjahn, and Esther Jung, “Explaining Attitudes and Adherence to Antipsychotic Medication: The Development of a Process Model,” Schizophrenia Research and Treatment, vol. 2014, pp. 1–11, 2014. View at Publisher · View at Google Scholar
  • Natália B. Mota, Raimundo Furtado, Pedro P. C. Maia, Mauro Copelli, and Sidarta Ribeiro, “Graph analysis of dream reports is especially informative about psychosis,” Scientific Reports, vol. 4, 2014. View at Publisher · View at Google Scholar
  • Junho Kim, Jong-Yeon Shin, Jong-Il Kim, Jeong-Sun Seo, Maree J. Webster, and Doheon Lee, “Somatic deletions implicated in functional diversity of brain cells of indi viduals with schizophrenia and unaffected controls,” Scientific Reports, vol. 4, 2014. View at Publisher · View at Google Scholar
  • F Fernandez-Enright, J L Andrews, K A Newell, C Pantelis, and X F Huang, “Novel implications of Lingo-1 and its signaling partners in schizophrenia,” Translational Psychiatry, vol. 4, no. 1, pp. e348, 2014. View at Publisher · View at Google Scholar
  • Steve Offord, Jay Lin, Dario Mirski, and Bruce Wong, “Impact of Early Nonadherence to Oral Antipsychotics on Clinical and Economic Outcomes Among Patients with Schizophrenia,” Advances in Therapy, vol. 30, no. 3, pp. 286–297, 2013. View at Publisher · View at Google Scholar
  • Mary V. Seeman, “Loss of Libido in a Woman With Schizophrenia,” American Journal of Psychiatry, vol. 170, no. 5, pp. 471–475, 2013. View at Publisher · View at Google Scholar
  • Brenda Happell, Robert Stanton, Wendy Hoey, and David Scott, “Development, validation and initial outcomes of a questionnaire to investigate the views of nurses working in a mental health setting regarding a cardiometabolic health nursing role,” Archives of Psychiatric Nursing, 2013. View at Publisher · View at Google Scholar
  • Xiaoyi Liu, Yunyao Lai, Xijin Wang, Chuanxi Hao, Lei Chen, Zhenyu Zhou, Xin Yu, and Nan Hong, “Reduced white matter integrity and cognitive deficit in never-medicated chronic schizophrenia: A diffusion tensor study using TBSS,” Behavioural Brain Research, 2013. View at Publisher · View at Google Scholar
  • Holly L. Redpath, Deborah Cooper, and Stephen M. Lawrie, “Imaging Symptoms and Syndromes: Similarities and Differences Between Schizo phrenia and Bipolar Disorder,” Biological Psychiatry, vol. 73, no. 6, pp. 495–496, 2013. View at Publisher · View at Google Scholar
  • Michelle K. Jetha, Xin Zheng, Joel O. Goldberg, Sidney J. Segalowitz, and Louis A. Schmidt, “Shyness and Emotional Face Processing in Schizophrenia: An ERP study,” Biological Psychology, 2013. View at Publisher · View at Google Scholar
  • Debra Jeffery, Sarah Clement, Elizabeth Corker, Louise M. Howard, Joanna Murray, and Graham Thornicroft, “Discrimination in relation to parenthood reported by community psychiatric service users in the UK: a framework analysis,” Bmc Psychiatry, vol. 13, 2013. View at Publisher · View at Google Scholar
  • E. Varga, M. Simon, T. Tényi, Zs. Schnell, A. Hajnal, G. Orsi, T. Dóczi, S. Komoly, J. Janszky, R. Füredi, E. Hamvas, S. Fekete, and R. Herold, “Irony comprehension and context processing in schizophrenia during remission – A functional MRI study,” Brain and Language, vol. 126, no. 3, pp. 231–242, 2013. View at Publisher · View at Google Scholar
  • Malgorzata Kowalczyk, Aleksander Owczarek, Renata Suchanek, Monika Paul-Samojedny, Anna Fila-Danilow, Paulina Borkowska, Krzysztof Kucia, and Jan Kowalski, “Heat shock protein 70 gene polymorphisms are associated with paranoid schizophrenia in the Polish population,” Cell Stress and Chaperones, 2013. View at Publisher · View at Google Scholar
  • Mario Alyarez-Jimenez, Kelly Allott, Sarah Bendall, and Patrick McGorry, “Community Rehabilitation and Psychosocial Interventions for Psychotic Disor ders in Youth,” Child and Adolescent Psychiatric Clinics of North America, vol. 22, no. 4, pp. 745–+, 2013. View at Publisher · View at Google Scholar
  • Patrizia Thoma, Denise Soria Bauser, Christine Norra, Martin Brüne, Georg Juckel, and Boris Suchan, “Do you see what I feel? – Electrophysiological correlates of emotional face and body perception in schizophrenia,” Clinical Neurophysiology, 2013. View at Publisher · View at Google Scholar
  • Ashok Malla, Pierre Chue, Gerald Jordan, Emmanuel Stip, David Koczerginski, Heather Milliken, Anil Joseph, Richard Williams, Beverly Adams, Rahul Manchanda, Kola Oyewumi, and Marc-André Roy, “An Exploratory Open-Label Randomized Trial Comparing Risperidone Long Acting Injectable (RLAI) with Oral Antipsychotic Medication in the Treatment of Early Psychosis,” Clinical Schizophrenia & Related Psychoses, vol. 1, no. -1, pp. 1–26, 2013. View at Publisher · View at Google Scholar
  • Giulio Scigliano, and Gabriele Ronchetti, “Antipsychotic-Induced Metabolic and Cardiovascular Side Effects in Schizoph renia: A Novel Mechanistic Hypothesis,” Cns Drugs, vol. 27, no. 4, pp. 249–257, 2013. View at Publisher · View at Google Scholar
  • Steffen Moritz, and Niels Van Quaquebeke, “Are you sure? Delusion conviction moderates the behavioural and emotional consequences of paranoid ideas,” Cognitive Neuropsychiatry, pp. 1–17, 2013. View at Publisher · View at Google Scholar
  • Robyn Langdon, Megan Still, Michael H. Connors, Philip B. Ward, and Stanley V. Catts, “Jumping to delusions in early psychosis,” Cognitive Neuropsychiatry, pp. 1–16, 2013. View at Publisher · View at Google Scholar
  • Carlo Marchesi, Andrea Affaticati, Alberto Monici, Chiara De Panfilis, Paolo Ossola, and Matteo Tonna, “Predictors of symptomatic remission in patients with first-episode schizophrenia: a 16 years follow-up study,” Comprehensive Psychiatry, 2013. View at Publisher · View at Google Scholar
  • Renaud Jardri, Julie Deguil, Benjamin Rolland, Olivier Cottencin, Pierre Thomas, and Regis Bordet, “Therapeutic Prospects of PPARs in Psychiatric Disorders: A Comprehensive Re view,” Current Drug Targets, vol. 14, no. 7, pp. 724–732, 2013. View at Publisher · View at Google Scholar
  • Julia Sacher, Peter Schoenknecht, Karsten Mueller, and Johann Steiner, “Serum S100B Represents a New Biomarker for Mood Disorders,” Current Drug Targets, vol. 14, no. 11, pp. 1237–1248, 2013. View at Publisher · View at Google Scholar
  • Robert McQuade, Suresh Mallikaarjun, Patricia Bricmont, William Kasper, Raymond Sanchez, Arash Raoufinia, Timothy Peters-Strickland, Ross A. Baker, and Anna Eramo, “Safety and tolerability of once monthly aripiprazole treatment initiation i n adults with schizophrenia stabilized on selected atypical oral antipsycho tics other than aripiprazole,” Current Medical Research And Opinion, vol. 29, no. 10, pp. 1241–1251, 2013. View at Publisher · View at Google Scholar
  • Thomas Becker, and Silke Wiegand-Grefe, “Mental health services for parents affected by mental illness,” Current Opinion in Psychiatry, vol. 26, no. 4, pp. 362–368, 2013. View at Publisher · View at Google Scholar
  • Melissa L. Perreault, Theresa Fan, and Brian F. O'Dowd, “Enhanced Brain-Derived Neurotrophic Factor Signaling in the Nucleus Accumbe ns of Juvenile Rats,” Developmental Neuroscience, vol. 35, no. 5, pp. 384–395, 2013. View at Publisher · View at Google Scholar
  • Christopher R. Bowie, Michael Grossman, Maya Gupta, L. Kola Oyewumi, and Philip D. Harvey, “Cognitive remediation in schizophrenia: efficacy and effectiveness in patients with early versus long-term course of illness,” Early Intervention in Psychiatry, 2013. View at Publisher · View at Google Scholar
  • Kelly Allott, Eoin Killackey, Ping Liu, Stephen J. Wood, and Andrew Thompson, “Social cognition training as an intervention for improving functional outco me in first-episode psychosis: a feasibility study,” Early Intervention in Psychiatry, vol. 7, no. 4, pp. 421–426, 2013. View at Publisher · View at Google Scholar
  • Guusje Collin, Marcel A. de Reus, Wiepke Cahn, Hilleke E. Hulshoff Pol, René S. Kahn, and Martijn P. van den Heuvel, “Disturbed grey matter coupling in schizophrenia,” European Neuropsychopharmacology, vol. 23, no. 1, pp. 46–54, 2013. View at Publisher · View at Google Scholar
  • Michael C. Davis, William P. Horan, and Stephen R. Marder, “Psychopharmacology of the Negative Symptoms of Schizophrenia: Current Status and Prospects for Progress,” European Neuropsychopharmacology, 2013. View at Publisher · View at Google Scholar
  • Rajesh Dubey, “Controlled-release injectable microemulsions: recent advances and potential opportunities,” Expert Opinion on Drug Delivery, pp. 1–15, 2013. View at Publisher · View at Google Scholar
  • Adrianna Mendrek, “Sex steroid hormones and brain function associated with cognitive and emotional processing in schizophrenia,” Expert Review of Endocrinology & Metabolism, vol. 8, no. 1, pp. 1–3, 2013. View at Publisher · View at Google Scholar
  • Andrew Gibbons, Piers Gillett, Chad A. Bousman, Ian P. Everall, Tammie T. Money, and Brian Dean, “Biomarker investigations related to pathophysiological pathways in schizoph renia and psychosis,” Frontiers In Cellular Neuroscience, vol. 7, 2013. View at Publisher · View at Google Scholar
  • Michael Osterheider, “"To see or not to see: that is the question." The "Protection-Against-Schiz ophrenia" (PaSZ) model: evidence from congenital blindness and visuo-cognit ive aberrations,” Frontiers in Psychology, vol. 4, 2013. View at Publisher · View at Google Scholar
  • Jamie Joseph, and Grace Bae, “Sex, symptom, and prernorbid social functioning associated with perceptual organization dysfunction in schizophrenia,” Frontiers in Psychology, vol. 4, 2013. View at Publisher · View at Google Scholar
  • Luiz Lana, and Peter J. Uhlhaas, “High-frequency neural oscillations and visual processing deficits in schizo phrenia,” Frontiers in Psychology, vol. 4, 2013. View at Publisher · View at Google Scholar
  • Carrie W. Holtzman, Daniel I. Shapiro, Allison N. MacDonald, Sandra M. Goulding, Elaine F. Walker, Arthur T. Ryan, and Joy L. Brasfield, “The development of psychotic disorders in adolescence: A potential role for hormones,” Hormones And Behavior, vol. 64, no. 2, pp. 411–419, 2013. View at Publisher · View at Google Scholar
  • Siti Norsyuhada Roffeei, Gavin P. Reynolds, Nor Zuraida Zainal, Mas Ayu Said, Ahmad Hatim, Syarinaz Ahmad Aida, and Zahurin Mohamed, “Association of ADRA2A and MTHFR gene polymorphisms with weight loss following antipsychotic switching to aripiprazole or ziprasidone,” Human Psychopharmacology: Clinical and Experimental, 2013. View at Publisher · View at Google Scholar
  • Josep Maria Haro, Diego Novick, Roberto Brugnoli, and Jordan Bertsch, “Changes in adherence and treatment costs following initiation of oral or de pot typical antipsychotics among previously non-adherent patients with schi zophrenia,” Human Psychopharmacology-Clinical And Experimental, vol. 28, no. 5, pp. 438–446, 2013. View at Publisher · View at Google Scholar
  • Albert Batalla, Pere Castellvi, Diego Hidalgo, Marta Garcia, Ana Ortiz, Iria Grande, Alexandre Pons, and Eduard Parellada, “Effectiveness of long-acting injectable risperidone versus oral antipsychot ics in the treatment of recent-onset schizophrenia: a case-control study,” International Clinical Psychopharmacology, vol. 28, no. 4, pp. 164–170, 2013. View at Publisher · View at Google Scholar
  • Lisa B. Dixon, and Howard H. Goldman, “Early Detection and Intervention in Schizophrenia A New Therapeutic Model,” Jama-Journal Of The American Medical Association, vol. 310, no. 7, pp. 689–690, 2013. View at Publisher · View at Google Scholar
  • Mark Brosnan, Emma Chapman, and Chris Ashwin, “Adolescents with Autism Spectrum Disorder Show a Circumspect Reasoning Bias Rather than ‘Jumping-to-Conclusions’,” Journal of Autism and Developmental Disorders, 2013. View at Publisher · View at Google Scholar
  • Paul A. Tiffin, and Patrick Welsh, “Practitioner Review: Schizophrenia spectrum disorders and the at-risk mental state for psychosis in children and adolescents - evidence-based management approaches,” Journal of Child Psychology and Psychiatry, 2013. View at Publisher · View at Google Scholar
  • Sven Haedel, Christoph Wirth, Michael Rapp, and Juergen Gallinat, “Effects of Age and Sex on the Concentrations of Glutamate and Glutamine in the Human Brain,” Journal of Magnetic Resonance Imaging, vol. 38, no. 6, pp. 1480–1487, 2013. View at Publisher · View at Google Scholar
  • Tomoko Shiino, Takayoshi Koide, Itaru Kushima, Masashi Ikeda, Shohko Kunimoto, Yukako Nakamura, Akira Yoshimi, Masahiro Banno, Tsutomu Kikuchi, Kunihiro Kohmura, Yasunori Adachi, Naoko Kawano, Takashi Okada, Toshiya Inada, Hiroshi Ujike, Tetsuya Iidaka, Michio Suzuki, Nakao Iwata, and Norio Ozaki, “Common Variants In Bcl9 Gene And Schizophrenia In A Japanese Population: As Sociation Study, Meta-Analysis And Cognitive Function Analysis,” Journal of Medical Biochemistry, vol. 32, no. 4, pp. 361–367, 2013. View at Publisher · View at Google Scholar
  • Souhel Najjar, Daniel M. Pearlman, Kenneth Alper, Amanda Najjar, and Orrin Devinsky, “Neuroinflammation and psychiatric illness,” Journal of Neuroinflammation, vol. 10, 2013. View at Publisher · View at Google Scholar
  • George R. Mangun, J. Daniel Ragland, Cameron S. Carter, Debra L. Long, Steve J. Luck, Tyler Lesh, Tara Niendam, Marjorie Solomon, Megan A. Boudewyn, Ann M. Kring, and Charan Ranganath, “Spared and Impaired Spoken Discourse Processing in Schizophrenia: Effects o f Local and Global Language Context,” Journal Of Neuroscience, vol. 33, no. 39, pp. 15578–15587, 2013. View at Publisher · View at Google Scholar
  • Miriam Melis, Simona Scheggi, Gianfranca Carta, Camilla Madeddu, Salvatore Lecca, Antonio Luchicchi, Francesca Cadeddu, Roberto Frau, Liana Fattore, Paola Fadda, M. Grazia Ennas, M. Paola Castelli, Walter Fratta, Bjorn Schilstrom, Sebastiano Banni, M. Graziella De Montis, and Marco Pistis, “PPAR alpha Regulates Cholinergic-Driven Activity of Midbrain Dopamine Neuro ns via a Novel Mechanism Involving alpha 7 Nicotinic Acetylcholine Receptor s,” Journal of Neuroscience, vol. 33, no. 14, pp. 6203–+, 2013. View at Publisher · View at Google Scholar
  • J. Connaughton, S. Patman, and C. Pardoe, “Are there associations among physical activity, fatigue, sleep quality and pain in people with mental illness? A pilot study,” Journal of Psychiatric and Mental Health Nursing, 2013. View at Publisher · View at Google Scholar
  • M. Valencia, A. Fresan, F. Juárez, R. Escamilla, and R. Saracco, “The beneficial effects of combining pharmacological and psychosocial treatment on remission and functional outcome in outpatients with schizophrenia,” Journal of Psychiatric Research, 2013. View at Publisher · View at Google Scholar
  • Roger Pamphlett, “Uptake of environmental toxicants by the locus ceruleus: a potential trigger for neurodegenerative, demyelinating, and psychiatric disorders,” Medical Hypotheses, 2013. View at Publisher · View at Google Scholar
  • Hong Yan Zhang, Fan Zhang, Manickam Thirunavukarasu, Jayashri Kulkarni, and Mingyuan Zhang, “Psychiatrists' awareness of partial and nonadherence to antipsychotic medic ation in schizophrenia: results from an Asia-Pacific survey,” Neuropsychiatric Disease And Treatment, vol. 9, pp. 1163–1170, 2013. View at Publisher · View at Google Scholar
  • Masayoshi Takahashi, Takayuki Saito, Misuzu Iizumi, Yuki Saito, Hiroko Shimizu, and Taka Matsumura, “Randomized, placebo-controlled, double-blind study assessing the efficacy a nd safety of paliperidone palmitate in Asian patients with schizophrenia,” Neuropsychiatric Disease and Treatment, vol. 9, pp. 1889–1897, 2013. View at Publisher · View at Google Scholar
  • I. Feinstein, and M.F. Kritzer, “Acute N-methyl-d-aspartate receptor hypofunction induced by MK801 evokes sex-specific changes in behaviors observed in open-field testing in adult male and proestrus female rats,” Neuroscience, vol. 228, pp. 200–214, 2013. View at Publisher · View at Google Scholar
  • C. H. Wu, C. Wong, C. Hercher, E. Toepfer, H. N. Boyda, R. M. Procyshyn, W. G. Honer, and C. L. Beasley, “Effects Of Chronic Exercise And Treatment With The Antipsychotic Drug Olanz Apine On Hippocampal Volume In Adult Female Rats,” Neuroscience, vol. 255, pp. 147–157, 2013. View at Publisher · View at Google Scholar
  • Keith A. Feigenson, Alex W. Kusnecov, and Steven M. Silverstein, “Inflammation and the two-hit hypothesis of schizophrenia,” Neuroscience & Biobehavioral Reviews, 2013. View at Publisher · View at Google Scholar
  • Handi Zhang, Yanbo Zhang, Haiyun Xu, Lingyan Wang, Jinsong Zhao, Junhui Wang, Zhijun Zhang, Qingrong Tan, Jiming Kong, and Qingjun Huang, “Locomotor activity and anxiety status, but not spatial working memory, are affected in mice after brief exposure to cuprizone,” Neuroscience Bulletin, vol. 29, no. 5, pp. 633–641, 2013. View at Publisher · View at Google Scholar
  • Farha Bilal Motiwala, and Kim Stasia Siscoe, “Review of depot aripiprazole for schizophrenia,” Patient Preference and Adherence, vol. 7, pp. 1181–1187, 2013. View at Publisher · View at Google Scholar
  • Julio Casoy, and Jacqueline Zummo, “Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophrenia,” Patient Preference and Adherence, vol. 7, pp. 1171–1180, 2013. View at Publisher · View at Google Scholar
  • Brenda Happell, David Scott, Wendy Hoey, and Robert Stanton, “Self-Reported Health, Health Behaviors, Attitudes, and Beliefs of Regional Mental Health Consumers,” Perspectives in Psychiatric Care, 2013. View at Publisher · View at Google Scholar
  • A. La Torre, A. Conca, D. Duffy, M. Pompili, and M. Groezinger, “Sexual Dysfunction Related to Psychotropic Drugs: A Critical Review Part II : Antipsychotics,” Pharmacopsychiatry, vol. 46, no. 6, pp. 201–208, 2013. View at Publisher · View at Google Scholar
  • Karin Langohr, Dorothee E. Mutschler, Stefan Klingberg, Barbara Wild, and Michael Erb, “Isn't it ironic? Neural Correlates of Irony Comprehension in Schizophrenia,” Plos One, vol. 8, no. 9, 2013. View at Publisher · View at Google Scholar
  • Jordan M. Ramsey, Emanuel Schwarz, Paul C. Guest, Nico J. M. van Beveren, F. Markus Leweke, Matthias Rothermundt, Bernhard Bogerts, and Johann Steiner, “Distinct Molecular Phenotypes in Male and Female Schizophrenia Patients,” Plos One, vol. 8, no. 11, 2013. View at Publisher · View at Google Scholar
  • Marta Statucka, and Deborah J. Walder, “Efficacy of social cognition remediation programs targeting facial affect recognition deficits in schizophrenia: A review and consideration of high-risk samples and sex differences,” Psychiatry Research, vol. 206, no. 2-3, pp. 125–139, 2013. View at Publisher · View at Google Scholar
  • Christina Andreou, Daniela Roesch-Ely, Ruth Veckenstedt, Francesca Bohn, Julia Aghotor, Ulf Köther, Ute Pfueller, and Steffen Moritz, “Predictors of early stable symptomatic remission after an exacerbation of schizophrenia: The significance of symptoms, neuropsychological performance and cognitive biases,” Psychiatry Research, 2013. View at Publisher · View at Google Scholar
  • Federica Pinna, Luca Deriu, Tiziana Lepori, Raffaela Maccioni, Paola Milia, Elisabetta Sarritzu, and Massimo Tusconi, “Is it true remission? A study of remitted patients affected by schizophreni a and schizoaffective disorders,” Psychiatry Research, vol. 210, no. 3, pp. 739–744, 2013. View at Publisher · View at Google Scholar
  • Steffen Moritz, Liz Rietschel, Ruth Veckenstedt, Francesca Bohn, Brooke C. Schneider, Tania M. Lincoln, and Anne Karow, “The other side of “madness”: frequencies of positive and ambivalent attitudes towards prominent positive symptoms in psychosis,” Psychosis, pp. 1–11, 2013. View at Publisher · View at Google Scholar
  • Joao Paulo Maia-de-Oliveira, Rodrigo A. Bressan, Helio Elkis, and Joao Paulo Machado-de-Sousa, “Why we should use long-acting injectable antipsychotics more frequently,” Revista Brasileira de Psiquiatria, vol. 35, no. 3, pp. 217–218, 2013. View at Publisher · View at Google Scholar
  • Else-Marie Loberg, Alexander R. Craven, Lars Ersland, Jan Oystein Berle, Rune A. Kroken, Erik Johnsen, and Kenneth Hugdahl, “Dichotic listening, executive functions and grey matter cortical volume in patients with schizophrenia and healthy controls,” Scandinavian Journal of Psychology, vol. 54, no. 6, pp. 443–450, 2013. View at Publisher · View at Google Scholar
  • Carin J. Meijer, Leo M. J. de Sonneville, Don H. Linszen, and Lieuwe de Haan, “The Effect of Motivational Interviewing on Medication Adherence and Hospita lization Rates in Nonadherent Patients with Multi-Episode Schizophrenia,” Schizophrenia Bulletin, vol. 39, no. 6, pp. 1242–1251, 2013. View at Publisher · View at Google Scholar
  • Gildas Brébion, Victoria Villalta-Gil, Jaume Autonell, Jorge Cervilla, Montserrat Dolz, Alexandrina Foix, Josep Maria Haro, Judith Usall, Miriam Vilaplana, and Susana Ochoa, “Cognitive correlates of verbal memory and verbal fluency in schizophrenia, and differential effects of various clinical symptoms between male and female patients,” Schizophrenia Research, vol. 147, no. 1, pp. 81–85, 2013. View at Publisher · View at Google Scholar
  • Pedro M. Paz-Alonso, Simona Ghetti, Ian Ramsay, Marjorie Solomon, Jong Yoon, Cameron S. Carter, and J. Daniel Ragland, “Semantic processes leading to true and false memory formation in schizophrenia,” Schizophrenia Research, 2013. View at Publisher · View at Google Scholar
  • Pascal Delamillieure, Elise Leroux, Mathieu Alary, Perrine Brazo, Nicolas Delcroix, and Annick Razafimandimby, “Functional and white matter abnormalities in the language network in patien ts with schizophrenia: A combined study with diffusion tensor imaging and f unctional magnetic resonance imaging,” Schizophrenia Research, vol. 150, no. 1, pp. 93–100, 2013. View at Publisher · View at Google Scholar
  • Anne E. Steinhaeuser, “Functional MRI of sentence-level language comprehension in schizophrenia: A coordinate-based analysis,” Schizophrenia Research, vol. 150, no. 1, pp. 107–113, 2013. View at Publisher · View at Google Scholar
  • Bianca Backasch, Benjamin Straube, Martin Pyka, Farahnaz Klöhn-Saghatolislam, Matthias J. Müller, Tilo T. J. Kircher, and Dirk T. Leube, “Hyperintentionality during automatic perception of naturalistic cooperative behavior in patients with schizophrenia,” Social Neuroscience, pp. 1–16, 2013. View at Publisher · View at Google Scholar
  • Elise Hall, and Meir Steiner, “Serotonin and female psychopathology,” Women's Health, vol. 9, no. 1, pp. 85–97, 2013. View at Publisher · View at Google Scholar
  • M. V. Seeman, “Clinical interventions for women with schizophrenia: pregnancy,” Acta Psychiatrica Scandinavica, vol. 127, no. 1, pp. 12–22, 2012. View at Publisher · View at Google Scholar
  • Grace J. Lee, Po H. Lu, Xue Hua, Suh Lee, Stephanie Wu, K Ken Nguyen, Edmond Teng, Alex D. Leow, Clifford R. Jack, Arthur W. Toga, Michael W. Weiner, George Bartzokis, and Paul M. Thompson, “Depressive Symptoms in Mild Cognitive Impairment Predict Greater Atrophy in Alzheimer's Disease-Related Regions,” Biological Psychiatry, vol. 71, no. 9, pp. 814–821, 2012. View at Publisher · View at Google Scholar
  • Giuseppe Rossi, Sonia Frediani, Roberta Rossi, and Andrea Rossi, “Long-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practice from naturalistic observations,” BMC Psychiatry, vol. 12, no. 1, pp. 122, 2012. View at Publisher · View at Google Scholar
  • M. E. Shenton, H. M. Hamoda, J. S. Schneiderman, S. Bouix, O. Pasternak, Y. Rathi, M.-A. Vu, M. P. Purohit, K. Helmer, I. Koerte, A. P. Lin, C.-F. Westin, R. Kikinis, M. Kubicki, R. A. Stern, and R. Zafonte, “A review of magnetic resonance imaging and diffusion tensor imaging findings in mild traumatic brain injury,” Brain Imaging and Behavior, vol. 6, no. 2, pp. 137–192, 2012. View at Publisher · View at Google Scholar
  • Hannah M. Schmidt, Mathias Hagen, Levente Kriston, Karla Soares-Weiser, Nicola Maayan, and Michael M. Berner, “Management of sexual dysfunction due to antipsychotic drug therapy,” Cochrane Database of Systematic Reviews, no. 11, 2012. View at Publisher · View at Google Scholar
  • H. Bugra, C. Rapp, E. Studerus, J. Aston, S. Borgwardt, and A. Riecher-Roessler, “Can Cannabis Use Increase the Risk for Schizophrenic Psychoses?,” Fortschritte der Neurologie Psychiatrie, vol. 80, no. 11, pp. 635–643, 2012. View at Publisher · View at Google Scholar
  • Cynthia G. Wible, “Hippocampal temporal-parietal junction interaction in the production of psy chotic symptoms: a framework for understanding the schizophrenic syndrome,” Frontiers in Human Neuroscience, vol. 6, 2012. View at Publisher · View at Google Scholar
  • Ahmed Mahmoud, Karen P. Hayhurst, Richard J. Drake, and Shon W. Lewis, “Sexual function of patients with schizophrenia receiving first-generation ( FGA) or second-generation antipsychotic (SGA) treatment,” International Journal of Psychiatry in Clinical Practice, vol. 16, no. 2, pp. 148–152, 2012. View at Publisher · View at Google Scholar